EGFR Monoclonal Antibody for Advanced Gastric Cancer

Clinical trial NCT04136600 · UNKNOWN

Trial details

NCT number: NCT04136600
Sponsor: Shanghai Changzheng Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric Cancer Cetuximab Nimotuzumab

Start date: 2019-07-01
Primary completion: 2021-08-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.